{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:16:28Z","timestamp":1783566988651,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cca.2021.07.010","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T01:34:37Z","timestamp":1626053677000},"page":"151-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021"],"prefix":"10.1016","volume":"521","author":[{"given":"Warren R.","family":"Korn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaddie L.","family":"Haviland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Toohey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Stickle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cca.2021.07.010_b0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2885.1988.tb00189.x","article-title":"Xylazine\u2013a review of its pharmacology and use in veterinary medicine","volume":"11","author":"Greene","year":"1988","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.cca.2021.07.010_b0010","doi-asserted-by":"crossref","unstructured":"K. Ruiz-Col\u00f3n, C. Chavez-Arias, J.E. D\u00edaz-Alcal\u00e1, M.A. Mart\u00ednez, Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature, Forensic Sci. Int. 240 (2014) 1-8. DOI: S0379-0738(14)00117-0 [pii].","DOI":"10.1016\/j.forsciint.2014.03.015"},{"key":"10.1016\/j.cca.2021.07.010_b0015","unstructured":"A.L.A. Mohr, T. Browne, D.M. Martin, B.K. Logan, Xylazine: A Toxic Adulterant Found in Illicit Street Drugs. Center for Forensic Science Research and Education (CFSRE). (2020). URL: https:\/\/www.npsdiscovery.org\/xylazine-a-toxic-adulterant-found-in-illicit-street-drugs\/."},{"key":"10.1016\/j.cca.2021.07.010_b0020","doi-asserted-by":"crossref","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019","author":"Johnson","year":"2021","journal-title":"Inj. Prev."},{"key":"10.1016\/j.cca.2021.07.010_b0025","unstructured":"A.J. Krotulski, J. Shinefeld, K. Viner, B.K. Logan, Drug Supply Assessment (Q1 2021): Philadelphia, Pennsylvania, USA, Center for Forensic Science Research and Education (CFSRE). (2021). URL: https:\/\/www.npsdiscovery.org\/drug-supply-assessment-q1-2021-philadelphia-pennsylvania-usa\/."},{"key":"10.1016\/j.cca.2021.07.010_b0030","unstructured":"D. Veilleux-Lemieux, A. Castel, D. Carrier, F. Beaudry, P. Vachon, Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats, J. Am. Assoc. Lab. Anim. Sci. 52 (2013) 567-570. DOI: 2013000567 [pii]."},{"issue":"1","key":"10.1016\/j.cca.2021.07.010_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jvp.12820","article-title":"Re-evaluation of the pharmacokinetics of xylazine administered to Thoroughbred horses","volume":"43","author":"Habershon\u2010Butcher","year":"2020","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.cca.2021.07.010_b0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jat\/27.7.513","article-title":"Analysis of fentanyl and norfentanyl in human plasma by liquid chromatography-tandem mass spectrometry using electrospray ionization","volume":"27","author":"Day","year":"2003","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.cca.2021.07.010_b0045","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jpba.2004.09.024","article-title":"Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC-MS\/MS","volume":"37","author":"Huynh","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"22","key":"10.1016\/j.cca.2021.07.010_b0050","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jchromb.2010.05.033","article-title":"Development and validation of a sensitive ultra performance liquid chromatography tandem mass spectrometry method for the analysis of fentanyl and its major metabolite norfentanyl in urine and whole blood in forensic context","volume":"878","author":"Verplaetse","year":"2010","journal-title":"J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.cca.2021.07.010_b0055","doi-asserted-by":"crossref","unstructured":"G.S. Doran, L.A. Bradbury, Quantitation of the anaesthetic xylazine in ovine plasma by LC-MS\/MS, J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci. 997 (2015) 81-84. DOI: S1570-0232(15)30042-8 [pii].","DOI":"10.1016\/j.jchromb.2015.06.005"},{"issue":"2","key":"10.1016\/j.cca.2021.07.010_b0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1556-4029.2007.00648.x","article-title":"Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office","volume":"53","author":"Wong","year":"2008","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.cca.2021.07.010_b0065","doi-asserted-by":"crossref","unstructured":"R.A. Torruella, Xylazine (veterinary sedative) use in Puerto Rico, Subst. Abuse Treat. Prev. Policy. 6 (2011) 7-597X-6-7. DOI: 10.1186\/1747-597X-6-7 [doi].","DOI":"10.1186\/1747-597X-6-7"},{"issue":"3","key":"10.1016\/j.cca.2021.07.010_b0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J. Urban Health."},{"issue":"1","key":"10.1016\/j.cca.2021.07.010_b0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/PAF.0000000000000622","article-title":"Xylazine, a Veterinary Tranquilizer, Detected in 42 Accidental Fentanyl Intoxication Deaths","volume":"42","author":"Nunez","year":"2021","journal-title":"Am. J. Forensic Med. Pathol."},{"issue":"7","key":"10.1016\/j.cca.2021.07.010_b0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40263-013-0084-8","article-title":"Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management","volume":"27","author":"Spiller","year":"2013","journal-title":"CNS Drugs."},{"key":"10.1016\/j.cca.2021.07.010_b0085","doi-asserted-by":"crossref","unstructured":"A.F. Barbuto, M.M. Burns, Clonidine Compounding Error: Bradycardia and Sedation in a Pediatric Patient, J. Emerg. Med. 59 (2020) 53-55. DOI: S0736-4679(20)30359-0 [pii].","DOI":"10.1016\/j.jemermed.2020.04.027"},{"key":"10.1016\/j.cca.2021.07.010_b0090","unstructured":"C.A. Hammett-Stabler, G.C. McMillin, Toxicology and the Clinical Laboratory, in: W.C. Clarke, D.R. Dufour (Eds.), Contemporary Practice in Clinical Chemistry, AACC Press, Washington, D.C, 2006, pp. 465-476. ISBN-978-1-59425-054-5."},{"key":"10.1016\/j.cca.2021.07.010_b0095","first-page":"714","article-title":"Potential antidote for Rompun (xylazine) in humans","volume":"98","author":"Mackintosh","year":"1985","journal-title":"N. Z. Med. J."},{"issue":"3","key":"10.1016\/j.cca.2021.07.010_b0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/15563657908989878","article-title":"Xylazine hydrochloridine (Rompun) overdose in man","volume":"15","author":"Carruthers","year":"1979","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cca.2021.07.010_b0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jat\/25.4.245","article-title":"Severe intoxication with the veterinary tranquilizer xylazine in humans","volume":"25","author":"Hoffmann","year":"2001","journal-title":"J. Anal. Toxicol."},{"issue":"12","key":"10.1016\/j.cca.2021.07.010_b0110","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/54.12.1267","article-title":"Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis","volume":"54","author":"Haberer","year":"1982","journal-title":"Br. J. Anaesth."},{"issue":"11","key":"10.1016\/j.cca.2021.07.010_b0115","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10","author":"Stotts","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.cca.2021.07.010_b0120","first-page":"CD002024","article-title":"Alpha\u2082-adrenergic agonists for the management of opioid withdrawal","volume":"2016","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:00:08Z","timestamp":1757862008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898121002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":24,"alternative-id":["S0009898121002412"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2021.07.010","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2021.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}